Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 115
  2. 116
  3. 117
  4. 118
  5. 119
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Atezolizumab Biosimilar -­ PE Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4018PE-50ug

IchorBio 		50 ug Anmelden
Vergleichen
Rituximab Biosimilar N297A Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011N297A-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Rituximab Biosimilar N297A Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011N297A-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Rituximab Biosimilar N297A Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011N297A-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Rituximab Biosimilar N297A Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011N297A-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Rituximab Biosimilar N297A Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011N297A-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Rituximab Biosimilar N297A Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011N297A-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Rituximab Biosimilar (LALAPG) -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011LALAPG-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Rituximab Biosimilar (LALAPG) -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011LALAPG-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Rituximab Biosimilar (LALAPG) -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011LALAPG-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Rituximab Biosimilar (LALAPG) -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011LALAPG-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Rituximab Biosimilar (LALAPG) -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011LALAPG-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Rituximab Biosimilar (LALAPG) -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu CHO cells ICH4011LALAPG-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Tocilizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu ICH4012-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Tocilizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu ICH4012-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Tocilizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu ICH4012-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Aflibercept Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu ICH4015-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ GAALIE Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH4004Fc-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ GAALIE Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH4004Fc-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ GAALIE Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH4004Fc-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ GAALIE Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH4004Fc-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ GAALIE Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH4004Fc-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ GAALIE Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH4004Fc-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Adalimumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4001B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Adalimumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4001D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Name Preis
Atezolizumab Biosimilar -­ PE Research Grade Anmelden Atezolizumab Biosimilar - PE Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 50 ug
Lieferbar
Rituximab Biosimilar N297A Research Grade Anmelden Rituximab Biosimilar N297A Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Rituximab Biosimilar N297A Research Grade Anmelden Rituximab Biosimilar N297A Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Rituximab Biosimilar N297A Research Grade Anmelden Rituximab Biosimilar N297A Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Rituximab Biosimilar N297A Research Grade Anmelden Rituximab Biosimilar N297A Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Rituximab Biosimilar N297A Research Grade Anmelden Rituximab Biosimilar N297A Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Rituximab Biosimilar N297A Research Grade Anmelden Rituximab Biosimilar N297A Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Rituximab Biosimilar (LALAPG) -­ Research Grade Anmelden Rituximab Biosimilar (LALAPG) - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Rituximab Biosimilar (LALAPG) -­ Research Grade Anmelden Rituximab Biosimilar (LALAPG) - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Rituximab Biosimilar (LALAPG) -­ Research Grade Anmelden Rituximab Biosimilar (LALAPG) - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Rituximab Biosimilar (LALAPG) -­ Research Grade Anmelden Rituximab Biosimilar (LALAPG) - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Rituximab Biosimilar (LALAPG) -­ Research Grade Anmelden Rituximab Biosimilar (LALAPG) - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Rituximab Biosimilar (LALAPG) -­ Research Grade Anmelden Rituximab Biosimilar (LALAPG) - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Tocilizumab Biosimilar -­ Research Grade Anmelden Tocilizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Tocilizumab Biosimilar -­ Research Grade Anmelden Tocilizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Tocilizumab Biosimilar -­ Research Grade Anmelden Tocilizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Aflibercept Biosimilar -­ Research Grade Anmelden Aflibercept Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Cetuximab Biosimilar -­ GAALIE Research Grade Anmelden Cetuximab Biosimilar - GAALIE Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Cetuximab Biosimilar -­ GAALIE Research Grade Anmelden Cetuximab Biosimilar - GAALIE Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Cetuximab Biosimilar -­ GAALIE Research Grade Anmelden Cetuximab Biosimilar - GAALIE Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Cetuximab Biosimilar -­ GAALIE Research Grade Anmelden Cetuximab Biosimilar - GAALIE Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Cetuximab Biosimilar -­ GAALIE Research Grade Anmelden Cetuximab Biosimilar - GAALIE Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Cetuximab Biosimilar -­ GAALIE Research Grade Anmelden Cetuximab Biosimilar - GAALIE Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Adalimumab Biosimilar -­ Biotin Research Grade Anmelden Adalimumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Adalimumab Biosimilar -­ Dylight488 Research Grade Anmelden Adalimumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 115
  2. 116
  3. 117
  4. 118
  5. 119
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top